{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/MDCX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MDCX"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","market":"US","secType":"STK","nameCN":"Medicus Pharma Ltd.","latestPrice":2.8538,"timestamp":1742320304240,"preClose":2.97,"halted":0,"volume":19280,"delay":0,"changeRate":-0.039125,"change":-0.1162,"floatShares":4049793,"shares":11726780,"lyrEps":0,"amount":58406.733671999995,"amplitude":0.118215,"volumeRatio":0.404565,"dividePrice":0,"prevYearClose":2.43,"fiveDayClose":2.61,"twentyDayClose":3.96},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","floatShares":4049793,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.404565,"shares":11726780,"dividePrice":0,"high":3.2011,"amplitude":0.118215,"preClose":2.97,"low":2.85,"week52Low":1.8,"pbRate":"--","week52High":4.99,"institutionHeld":0,"latestPrice":2.8538,"committee":-0.715302,"eps":0,"divideRate":0,"volume":19280,"delay":0,"ttmEps":0,"open":3.1,"prevYearClose":2.43,"prevWeekClose":3.29,"prevMonthClose":3.99,"prevQuarterClose":2.43,"fiveDayClose":2.61,"twentyDayClose":3.96,"sixtyDayClose":2.64},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDCX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDCX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDCX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1735185600000},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MDCX\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MDCX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518970785","title":"Medicus Pharma Secures $4.2 Million for Innovative Skin Treatment Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2518970785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518970785?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:43","pubTimestamp":1741639421,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd ( ($MDCX) ) just unveiled an announcement. Medicus Pharma Ltd. has successfully closed a $4.2 million Tier II Regulation A offer...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-secures-4-2-million-for-innovative-skin-treatment-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-secures-4-2-million-for-innovative-skin-treatment-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCX","BK4139"],"gpt_icon":0},{"id":"2518278856","title":"Medicus Pharma Ltd. Announces Closing of $4.2 Million Regulation A Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2518278856","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518278856?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:05","pubTimestamp":1741637100,"startTime":"0","endTime":"0","summary":"Philadelphia, Pennsylvania-- - Medicus Pharma Ltd.   today announced the closing of its previously announced Tier II Regulation A offering of 1,490,000 units, on a \"best-efforts\" basis, at a price of $2.80 per unit. Each unit consisted of one common share of the Company and one warrant to purchase one common share. The warrants have an exercise price of $2.80 per share and will expire 5 years from the date of issuance.The common shares are listed on The Nasdaq Capital Market under the symbol \"MDCX\". The warrants will not trade on any securities exchange.SkinJect Inc. a wholly owned subsidiary of Medicus Pharma Ltd, is a development stage, life sciences company focused on commercializing novel, non-invasive treatment for basal cell skin cancer using patented dissolvable microneedle patch to deliver chemotherapeutic agent to eradicate tumors cells. The Company has completed a phase 1 safety & to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/medicus-pharma-ltd-announces-closing-200500644.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medicus-pharma-ltd-announces-closing-200500644.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MDCX","BK4139","MDCXW"],"gpt_icon":0},{"id":"2517581894","title":"Medicus Pharma Ltd: Promising Phase 2 Results and Market Potential Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2517581894","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517581894?lang=en_us&edition=fundamental","pubTime":"2025-03-08 00:25","pubTimestamp":1741364753,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd (MDCX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jason McCarth...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/medicus-pharma-ltd-promising-phase-2-results-and-market-potential-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/medicus-pharma-ltd-promising-phase-2-results-and-market-potential-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCX"],"gpt_icon":0},{"id":"2517914645","title":"Medicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2517914645","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517914645?lang=en_us&edition=fundamental","pubTime":"2025-03-07 09:30","pubTimestamp":1741311000,"startTime":"0","endTime":"0","summary":"Philadelphia, Pennsylvania-- - Medicus Pharma Ltd.   today announced the pricing of its Tier II Regulation A offering of 1,490,000 units, on a \"best-efforts\" basis, at a price of $2.80 per unit. Each unit consists of one common share of the Company and one warrant to purchase one common share. The warrants will have an exercise price of $2.80 per share and will expire 5 years from the date of issuance.The common shares are listed on The Nasdaq Capital Market under the symbol \"MDCX\". The warrants will not trade on any securities exchange. The offering is expected to close on March 10, 2025, subject to customary closing conditions.SkinJect Inc. a wholly owned subsidiary of Medicus Pharma Ltd, is a development stage, life sciences company focused on commercializing novel, non-invasive treatment for basal cell skin cancer using patented dissolvable microneedle patch to deliver chemotherapeutic agent to eradicate tumors cells. The Company has completed a phase 1 safety & toler","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/medicus-pharma-ltd-announces-pricing-013000820.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medicus-pharma-ltd-announces-pricing-013000820.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MDCX","BK4139","MDCXW"],"gpt_icon":0}],"pageSize":4,"totalPage":9,"pageCount":1,"totalSize":35}]}}